Larimar Therapeutics
LRMR
#6459
Rank
$0.57 B
Marketcap
$7.94
Share price
-12.17%
Change (1 day)
232.22%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$0.92

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.92. In 2022 the company made an earnings per share (EPS) of -$1.54 an increase over its 2021 EPS that were of -$2.97.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.92-40.26%
2022-$1.54-48.15%
2021-$2.97-14.27%
2020-$3.46